Dostarlimab

dostarlimab-1753217360207-389892

Description

Dostarlimab, sold under the brand name Jemperli, is a monoclonal antibody used as an anti-cancer medication for the treatment of endometrial cancer. Dostarlimab is a programmed death receptor-1 (PD-1)–blocking monoclonal antibody.

ID: dostarlimab-1753217360207-389892

Share this TL;DR